Radiation Therapy and Cisplatin in Treating Patients With Stage I Bladder Cancer

Official Title

A Phase II Protocol for Patients With Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent With Cisplatin Chemotherapy Following a Thorough Transurethral Surgical Re-Staging


RATIONALE: Radiation therapy uses high-energy x-rays to kill tumour cells. Specialized radiation therapy that delivers a high dose of radiation directly to the tumour may kill more tumour cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin, work in different ways to stop the growth of tumour cells, either by killing the cells or by stopping them from dividing. Giving radiation therapy together with cisplatin may kill more tumour cells.

PURPOSE: This phase II trial is studying how well radiation therapy given together with cisplatin works in treating patients with stage I bladder cancer.

Trial Description

View this trial on ClinicalTrials.gov

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.


Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society